Point72 Asset Management L.P. lifted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 1,593.0% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 854,945 shares of the company’s stock after purchasing an additional 804,445 shares during the period. Point72 Asset Management L.P. owned about 0.54% of Henry Schein worth $70,097,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Alecta Pensionsforsakring Omsesidigt raised its stake in Henry Schein by 112.0% during the 3rd quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock worth $435,693,000 after acquiring an additional 2,806,990 shares during the period. Mackenzie Financial Corp raised its stake in Henry Schein by 106.0% during the 3rd quarter. Mackenzie Financial Corp now owns 3,938,233 shares of the company’s stock worth $322,896,000 after acquiring an additional 2,026,867 shares during the period. Janus Henderson Group PLC raised its stake in Henry Schein by 92.1% during the 3rd quarter. Janus Henderson Group PLC now owns 2,814,636 shares of the company’s stock worth $230,777,000 after acquiring an additional 1,349,333 shares during the period. Atlanta Capital Management Co. L L C raised its stake in Henry Schein by 99.4% during the 3rd quarter. Atlanta Capital Management Co. L L C now owns 2,493,054 shares of the company’s stock worth $204,405,000 after acquiring an additional 1,242,849 shares during the period. Finally, Swedbank raised its stake in Henry Schein by 84.9% during the 3rd quarter. Swedbank now owns 2,358,594 shares of the company’s stock worth $193,381,000 after acquiring an additional 1,083,115 shares during the period. Hedge funds and other institutional investors own 91.69% of the company’s stock.
In other news, Director Barry J. Alperin sold 5,796 shares of Henry Schein stock in a transaction on Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the completion of the sale, the director now directly owns 48,172 shares in the company, valued at $3,408,650.72. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.19% of the stock is currently owned by company insiders.
A number of equities research analysts have commented on HSIC shares. Craig Hallum upgraded shares of Henry Schein from a “hold” rating to a “buy” rating in a research note on Tuesday, November 7th. UBS Group restated a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. Robert W. Baird set a $95.00 price objective on shares of Henry Schein and gave the company a “buy” rating in a research report on Thursday, October 19th. Deutsche Bank initiated coverage on shares of Henry Schein in a research report on Friday, December 8th. They set a “buy” rating and a $79.00 price objective on the stock. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $78.00 price objective on shares of Henry Schein in a research report on Wednesday, December 27th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the company’s stock. Henry Schein has an average rating of “Hold” and an average target price of $86.21.
Henry Schein, Inc. (NASDAQ HSIC) traded up $1.59 during midday trading on Tuesday, reaching $71.47. 1,243,207 shares of the company’s stock traded hands, compared to its average volume of 1,108,100. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.86. The stock has a market capitalization of $11,220.00, a price-to-earnings ratio of 20.60, a price-to-earnings-growth ratio of 1.97 and a beta of 0.99. Henry Schein, Inc. has a 52 week low of $65.28 and a 52 week high of $93.50.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, November 6th. The company reported $0.87 EPS for the quarter, missing the consensus estimate of $0.90 by ($0.03). The firm had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The firm’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.84 earnings per share. research analysts anticipate that Henry Schein, Inc. will post 3.6 EPS for the current fiscal year.
Henry Schein announced that its board has authorized a stock repurchase program on Monday, September 18th that allows the company to buyback $400.00 million in shares. This buyback authorization allows the company to purchase up to 6.3% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its shares are undervalued.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.